First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 345.87 USD -1.06% Market Closed
Updated: Mar 29, 2024

Wall Street
Price Targets

BIO Price Targets Summary
Bio Rad Laboratories Inc

Wall Street analysts forecast BIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO is 426.36 USD with a low forecast of 353.5 USD and a high forecast of 504 USD.

Lowest
Price Target
353.5 USD
2% Upside
Average
Price Target
426.36 USD
23% Upside
Highest
Price Target
504 USD
46% Upside
Bio Rad Laboratories Inc Competitors:
Price Targets
OLK
Olink Holding AB (publ)
13% Upside
ORPH
Open Orphan PLC
199% Upside
OABI
OmniAb Inc
81% Upside
PACB
Pacific Biosciences of California Inc
204% Upside
237690
ST Pharm Co Ltd
19% Upside
TXG
10X Genomics Inc
57% Upside
HVO
hVIVO PLC
16% Upside
DIVISLAB
Divi's Laboratories Ltd
4% Downside

Revenue
Forecast

Revenue Estimate
Bio Rad Laboratories Inc

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 4%. The projected CAGR for the next 3 years is 4%.

4%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bio Rad Laboratories Inc

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 10%. The projected CAGR for the next 3 years is 8%.

10%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Bio Rad Laboratories Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Price Target
426.36 USD

According to Wall Street analysts, the average 1-year price target for BIO is 426.36 USD with a low forecast of 353.5 USD and a high forecast of 504 USD.

What is Bio Rad Laboratories Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's revenue is 4%. The projected CAGR for the next 3 years is 4%.

What is Bio Rad Laboratories Inc's Operating Income forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Bio Rad Laboratories Inc's operating income is 10%. The projected CAGR for the next 3 years is 8%.